Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2259-2271
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2259
Table 3 Univariable and multivariable Cox regression analyses of clinicopathological factors for recurrence free survival
CharacteristicUnivariable analysis
Multivariable analysis
HR (95%CI)
P value
HR (95%CI)
P value
Textbook outcome
    NoReferenceReference
    Yes0.607 (0.382-0.963)0.0340.379 (0.228-0.629)< 0.001
Year of surgery
    1998-2010Reference
    2011-20201.030 (0.703-1.509)0.879
Sex
    MaleReference
    Female1.009 (0.685-1.485)0.965
Age (yr)
    ≤ 60Reference
    > 600.972 (0.652-1.449)0.891
Operation time (h)
    ≤ 6Reference
    > 61.051 (0.689-1.603)0.818
Blood transfusion
    NoReference
    Yes0.932 (0.638-1.363)0.717
Tumor size (cm)
    ≤ 2.0ReferenceReference
    > 2.01.540 (1.051-2.257)0.0271.365 (0.909-2.048)0.133
Differentiation
    PoorReferenceReference
    Moderate1.112 (0.730-1.693)0.6221.472 (0.946-2.290)0.086
    Well0.546 (0.307-0.974)0.0401.002 (0.508-1.976)0.997
CA199
    0-40Reference
    > 401.751 (1.145-2.677)0.0101.601 (1.025-2.501)0.038
    Unknown1.225 (0.584-2.568)0.5911.646 (0.746-3.634)0.217
N stage
    N0ReferenceReference
    N11.801 (1.170-2.771)0.0081.675 (1.006-2.789)0.047
    N22.563 (1.173-5.604)0.0181.807 (0.833-4.138)0.162
T stage
    T1ReferenceReference
    T21.152 (0.613-2.166)0.6610.885 (0.446-1.754)0.726
    T32.488 (1.387-4.463)0.0021.419 (0.709-2.842)0.323
Lymphovascular invasion
    NoReferenceReference
    Yes2.002 (1.321-3.033)0.0011.892 (1.161-3.081)0.010
Adjuvant treatment
    NoReference
    Yes1.271 (0.730-2.215)0.397
    Unknown0.671 (0.405-1.112)0.122